|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | 3M Co. (NYSE: MMM) | Biotrace International PLC |
| Strengthens 3M's position in providing hygiene monitoring and microbiological tests to the food, beverage and dairy sectors. Deal Value - more... | ||
| Biopharmaceuticals | Abbott (NYSE: ABT) | Kos Pharmaceuticals, Inc. |
| Expands Abbott's presence in lipid management market and strengthens its late-stage pipeline. The lipid management market is the single largest more... | ||
| Biopharmaceuticals | Actelion Ltd (Swiss:ATLN.SW) | CoTherix, Inc. (NASDAQ:CTRX ), |
| Acquired the only approved inhaled therapy for the treatment of Pulmonary Arterial Hypertension in the United States. Sales are now $60m, but more... | ||
| Biopharmaceuticals | AmerisourceBergen Corporation (NYSE:ABC) | IgG of America, Inc. |
| Supports ABC's strategy of building up its specialty pharmaceutical services. Deal value -- $35m plus $8.5m earnout, on revenue of $29m more... | ||
| Biopharmaceuticals | Barr Pharmaceuticals, Inc. (NYSE: BRL) | PLIVA d.d. (LSE: PLVD; ZSE: PLVA-R-A) |
| Creates the third largest global generic pharmaceutical company, based on revenue. The combined company will have a presence in over 30 countries and more... | ||
| Biopharmaceuticals | Boehringer Ingelheim Pharmaceuticals, Inc. | The US rights to the(OTC) Zantac® product line from J&J (NYSE:JNJ) & Pfizer Inc. (NYSE:PFE) |
| Zantac will be distributed through the same retail channels as Boehringer's current Dulcolax® business. Divested in keeping with the more... | ||
| Biopharmaceuticals | Eli Lilly and Company (NYSE: LLY) | ICOS Corporation (NASDAQ: ICOS) |
| Cialis to generate about $1b in '06 and has about a 26% US market share. Active ingredient may also treat swelling of the prostate known as BPH, more... | ||
| Biopharmaceuticals | Endo Pharmaceuticals Inc. (Nasdaq: ENDP) | RxKinetix, Inc. |
| Expands product line complementary to pain management, with new formulations of approved products for oral mucositis and other supportive care more... | ||
| Biopharmaceuticals | Forest Laboratories, Inc. (NYSE: FRX) | Cerexa, Inc. |
| Forest obtains worldwide development and marketing rights (excluding Japan) to two injectable antibiotics addressing hospital-borne infections and an more... | ||
| Biopharmaceuticals | Fresenius Medical Care AG & Co. KGaA | The phosphate binder business from Nabi Biopharmaceuticals Inc.( NABI) |
| Expands Fresenius' clinical therapy offerings, to better manage bone mineralization during dialysis treatment. Deal value -- $65m plus $20m in more... | ||
| Biopharmaceuticals | Genentech, Inc. (NYSE: DNA) | Tanox, Inc. (Nasdaq: TNOX) |
| Genentech and Tanox have been working together in collaboration with Novartis since 1996 to develop and commercialize Xolair®, an anti-IgE more... | ||
| Biopharmaceuticals | Gilead Sciences, Inc. (NASDAQ: GILD) | Raylo Chemicals Inc. |
| Will be used to scale-up clinical development candidates, for manufacturing of active pharmaceutical ingredients for investigational and commercial more... | ||
| Biopharmaceuticals | Gilead Sciences, Inc. (Nasdaq:GILD) | Myogen, Inc. (Nasdaq:MYOG) |
| Adds late-stage product candidates addressing Gilead's growing focus on pulmonology. Deal value -- more... | ||
| Biopharmaceuticals | GlaxoSmithKline Plc (GSK.L) | Domantis Ltd. |
| Domantis' experimental treatments are still in preclinical development, but provide for a long-term investment, some would say "bet". more... | ||
| Biopharmaceuticals | GlaxoSmithKline Plc (GSK.L) | Pracecis Pharmaceuticals Incorporated (Nasdaq: PRCS) |
| Praecis' therapeutic programs and chemical-synthesis and screening technology complements Glaxo's R&D capabilities. Deal value -- more... | ||
| Biopharmaceuticals | Graceway Pharmaceuticals, Inc | 3M's branded pharmaceutical business in the US, Puerto Rico, Canada and Latin America |
| An opportunistic purchase by a private equity firm (GTCR) portfolio company, extending its offering of branded prescription products in these areas. more... | ||
| Biopharmaceuticals | Lonza Group | The Research Bioproducts and the Microbial Biopharmaceutical business units from Cambrex. |
| Accelerates Lonza's strategic shift towards life sciences. Deal value -- more... | ||
| Biopharmaceuticals | Mayne Pharma Ltd. (ASX: MYP) | Worldwide rights to Nipent® from SuperGen Inc. (Nasdaq: SUPG) |
| Strengthens Mayne's oncology focus across Europe. Deal price -- more... | ||
| Biopharmaceuticals | Merck & Co., Inc. (NYSE: MRK) | Sirna Therapeutics, Inc. (NASDAQ: RNAI) |
| Enhances Merck's position in RNAi technology (used in drug discovery and development). Deal value - more... | ||
| Biopharmaceuticals | Pfizer Inc (NYSE: PFE) | PowderMed Ltd. |
| Offers new technology and needle-free delivery system shown to elicit both antibody and cell mediated immune responses. Terms not more... | ||
| Biopharmaceuticals | Pharmos Corporation (NASDAQ: PARS ) | Vela Pharmaceuticals |
| Broadens Pharmos' pipeline with later stage products targeting irritable bowel syndrome, pain/inflammation, and autoimmune diseases. Affiliates more... | ||
| Biopharmaceuticals | RheoGene, Inc. | Intrexon Corporation |
| RheoGene has developed technology to manage gene expression - a key component of gene-based therapies. The companies offer complementary gene-based more... | ||
| Biopharmaceuticals | Sangamo BioSciences, Inc. (NASDAQ: SGMO) | Angiogenesis Program of Edwards Lifesciences Corporation (NYSE: EW) |
| Provides for combined development of the companies' ZFP (zinc finger DNA-binding protein) therapeutics programs. Deal value - $6m in more... | ||
| Biopharmaceuticals | Stiefel Laboratories Inc. | Connetics Corporation (Nasdaq: CNCT) |
| Create a premier dermatology drug company. Deal value -- $640m, on $150m of revenue more... | ||
| Biopharmaceuticals | Watson Pharmaceuticals, Inc. (NYSE: WPI) | Andrx Corporation |
| The Andrx distribution business, offering generic products from manufacturers around the world, will diversify and stabilize Watson, providing steady more... | ||
| Data Management/ Healthcare IT | 3M Health Information Systems | SoftMED Systems |
| Brings to 3M solutions that enable hospitals to create an electronic medical record using templates, voice dictation, speech recognition, electronic more... | ||
| Data Management/ Healthcare IT | Cardinal Health (NYSE:CAH) | Care Fusion Inc. |
| Care Fusion's wireless technology permits scanning of patient barcoded wristbands and verifying proper medication, lab testing and procedures. more... | ||
| Data Management/ Healthcare IT | MCF Corporation (AMEX: MEM) | MedPanel, Inc. |
| Combines MedPanel' health care industry and financial services customers with MCF's sell side research, institutional investors and health more... | ||
| Dental | Zila, Inc. (NASDAQ GM: ZILA) | Professional Dental Technologies, Inc. |
| Completes Zila's transformation into a cancer diagnostic company focused initially on oral cancer. By leveraging target's national dental more... | ||
| Diagnostics | Beckman Coulter Inc.(NYSE: BEC) | Lumigen Inc. |
| Lumigen's proprietary chemiluminescent chemistry is the detection method used in Beckman's immunoassay systems. Deal value -- $185m, on $33m more... | ||
| Diagnostics | Becton, Dickinson and Company (NYSE: BDX ) | TriPath Imaging (NASDAQ: TPTH) |
| Expands BD's presence in cancer diagnostics. Synergizes with BD's flow cytometry and biomarker systems for detection of lymphoma and more... | ||
| Diagnostics | Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) | The ProteinChip Systems® & rights to Surface Enhanced Laser Desorption/ Ionization of Ciphergen Biosystems, Inc. |
| Provides Bio-Rad with access to leading protein analysis technology. Deal Price - more... | ||
| Diagnostics | Borealis Infrastructure Management Inc. | MDS Diagnostic Services, the laboratory services business of MDS Inc. (NYSE: MDZ) |
| MDS is Canada's largest provider of laboratory services, with annualized revenues of $289m (3.9x) and over 2,900 employees . Deal value -- more... | ||
| Diagnostics | Danaher Corporation (NYSE: DHR) | Vision Systems Limited (ASX: VSL) |
| Vision's pathology diagnostics instrument and consumable product offering fits well with DHR's Medical Technology Platform. Deal value - more... | ||
| Diagnostics | Genetix Group plc. (AIM: GTX) | Applied Imaging Corporation |
| Strengthens Genetix's capabilities in cell imaging and analysis and will enable expansion in the US, Europe and Asia. Deal price - more... | ||
| Diagnostics | Magellan Biosciences | TREK Diagnostic Systems |
| Expands Magellan’s commercial presence in clinical diagnostics. Terms not more... | ||
| Diagnostics | Microlife Corporation | HealtheTech, Inc. |
| Brings together complimentary products and allows Microlife to offer solutions specifically geared towards weight management. Terms not more... | ||
| Diagnostics | PerkinElmer, Inc. (NYSE: PKI) | Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) |
| Provides customers with new high content screening tools to increase speed and accuracy of cellular and drug discoveries. Deal value -- more... | ||
| Diagnostics | Primedex Health Systems, Inc. (OTCBB:PMDX) | Radiologix, Inc. (AMEX:RGX) |
| Expands Primedex's presence in California and provides a platform for growth outside of California. Primedex will further its strategies of more... | ||
| Diagnostics | Royal Philips Electronics (NYSE: PHG; AEX: PHI) | Intermagnetics General Corporation (Nasdaq: IMGC ) |
| Strengthens Phillips's MRI business and makes its supply chain more efficient, while diversifying away from businesses that are sensitive to more... | ||
| Diagnostics | Thermo Electron Corporation (NYSE: TMO) | Fisher Scientific International Inc. (NYSE: FSH ) |
| Will create the leading provider of laboratory products and services in the laboratory and health sciences industries. Complementary lines in more... | ||
| Diagnostics | Thoratec Corporation (NASDAQ: THOR) | A-VOX Systems, Inc. |
| Broadens Thoratec's offerings for hospital POC testing, particularly in the cardiac cath lab where Avox has an industry-leading presence. more... | ||
| Medical Devices | Andover Medical, Inc. (OTCBB:ADOV.OB) | Rainier Surgical Inc. |
| Adds new orthopedic products and distribution channels, serving as the springboard for further growth in the orthopedic medical more... | ||
| Medical Devices | Andover Medical, Inc. (OTCBB:ADOV.OB) | SRS Medical Systems, Inc. |
| Strengthens Andover's position for diagnosing and treating more... | ||
| Medical Devices | AngioDynamics, Inc. (NASDAQ:ANGO) | Oncobionic, Inc. |
| Acquired technology holds the potential to safely treat a wide range of diseases from liver tumors to prostate cancer quickly and efficiently. Deal more... | ||
| Medical Devices | AngioDynamics, Inc. (NASDAQ:ANGO) | RITA Medical Systems, Inc. (NASDAQ:RITA |
| Creates a diversified producer of access, diagnostic and therapeutic products that enable interventional physicians and surgeons to treat peripheral more... | ||
| Medical Devices | Anodyne Medical Device, Inc. | Anatomic Concepts, Inc. |
| Extends Anodyne's foam mattress and patient positioning business. Terms not more... | ||
| Medical Devices | ATS Medical, Inc. (Nasdaq: ATSI ) | 3F Therapeutics |
| 3F's heart valve replacement solutions will help build ATS' heart valve therapy platform. Stock deal valued at - $21m, plus $23m in stock more... | ||
| Medical Devices | ATS Medical, Inc. (NASDAQ: ATSI) | Certain assets of EM Vascular, Inc. |
| Acquired IP may lead to treatments of common vascular and blood disorders -- noninvasive, non-pharma therapies for the treatment of atherosclerotic more... | ||
| Medical Devices | Bovie Medical Corporation (Amex: BVX ) | Certain assets of Lican Developments LTD |
| Bovie buys disposable tip technology complementary to Bovie's previously acquired and announced Modular Ergonomic Grip (MEG) forceps, plus a new more... | ||
| Medical Devices | Brady Corporation (NYSE: BRC) | Precision Converters, Inc |
| Adds breadth and strength to Brady's medical die-cut business capabilities. Target sales of $10m. Terms not more... | ||
| Medical Devices | Cytyc Corporation (Nasdaq: CYTC) | Certain assets of Helica Instruments Limited |
| Cytec acquires minimally invasive surgical devices for treating endometriosis. Deal value -- $9m including more... | ||
| Medical Devices | Encore Medical Corporation | Cefar AB |
| Strategic addition to Encore's electrotherapy business, adding a substantial European presence in medical and consumer markets. Terms not more... | ||
| Medical Devices | Getinge AB | Huntleigh Technology Plc |
| Integrates hospital bedside management by combining lifters, support surfaces and beds. Getinge's Extended Care unit deals with patient handling, more... | ||
| Medical Devices | HAPC Inc | The InfuSystem Inc. unit of I-Flow Corporation |
| InfuSystems provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and their patients. more... | ||
| Medical Devices | Kyphon Inc. (Nasdaq: KYPH) | The spine-related product assets and rights of Disc-O-Tech Medical Technologies, Ltd. |
| Disc-O-Tech's portfolio includes an expandable interbody device for minimally invasive fusion in patients with degenerative disc disease, a more... | ||
| Medical Devices | Langer, Inc. (Nasdaq: GAIT) | Twincraft Inc. |
| Expands Langer's skincare/personal care categories, forming a new platform. Deal price - $26.7m, plus earnouts. Twincraft sales were about $27.1 more... | ||
| Medical Devices | Langer, Inc. (Nasdaq: GAIT) | Regal Medical Supply, LLC |
| Regal offers custom orthotic products into various long term care settings, plus the potential to create multi-location distribution systems, more... | ||
| Medical Devices | Medical Action Industries Inc. (NASDAQ:MDCI) | The Medical Products Division of Medegen Medical Products LLC |
| 10th and biggest acquisition for MDCI. Diversifies its product offerings and adds customers (in alternate sites) outside its current channels of more... | ||
| Medical Devices | Microtek Medical Holdings, Inc. (Nasdaq: MTMD) | Europlak |
| Part of Microtek's international growth strategy. Terms undisclosed. Revenue less than more... | ||
| Medical Devices | Micrus Endovascular Corporation (NASDAQ: MEND) | VasCon LLC Micrus Design Technology, Inc. |
| Expands Micrus' core competencies; part of its strategy to become a full-line endovascular company, addressing the neurointerventional market. more... | ||
| Medical Devices | Natus Medical Incorporated (Nasdaq:BABY) | Olympic Medical Corporation |
| Broadens Natus' product offerings in newborn market and leverages its direct sales force in the U.S. and international distribution organization. more... | ||
| Medical Devices | Teleflex Incorporated (NYSE:TFX) | Taut Inc. |
| Taut's bladeless laparoscopic access ports (trocars) have been distributed in Europe by Teleflex and complement its product lines. Teleflex has more... | ||
| Medical Devices | Texas Pacific Group | Transfusion Therapies business of Baxter International Inc. |
| Expands Texas Pacific's assets in the healthcare arena by adding blood-collection products and storage equipment as well as five manufacturing more... | ||
| Medical Devices | VIASYS Healthcare Inc. (NYSE:VAS) | BioBeat Medical, Ltd. |
| For $4.5m, Viasys acquires advanced Diigital Transcranial Doppler (TCD) technology, a non-invasive method of measuring blood flow velocities in the more... | ||
| Medical Devices | VIASYS Healthcare Inc. (NYSE:VAS) | Hoffman Laboratories, LLC |
| Increases VIASYS' presence in the global sleep therapy market, a fast growing part of the respiratory market. VIASYS is already a market leader more... | ||
| Medical Services | AIG Altaris Health Partners, Dynamic Healthcare Solutions, Salix Ventures and Three Arch Partners | U.S. HealthWorks |
| Three Arch Partners and Salix Ventures have maintained investments in U.S. HealthWorks since 2001. New investors seek further growth in keeping with more... | ||
| Medical Services | Airgas, Inc. (NYSE: ARG) | The U.S. bulk gas business that Linde AG (LIN.DE) |
| The bulk gas divestiture is being made in keeping with Linde's acquisition of BOC. The acquired assets complements the six existing air more... | ||
| Medical Services | Almost Family (NASDAQ: AFAM) | Mederi Inc. |
| Expands AFAM to 73 service locations in Florida, Kentucky, Ohio, Connecticut, Massachusetts, Missouri, Illinois, Alabama and Indiana. Deal price more... | ||
| Medical Services | AmerisourceBergen (NYSE:ABC) | Kindred Healthcare, Inc. (NYSE:KND) |
| The two companies are combining their institutional pharmacy businesses making it the second largest in the industry, with revenues of approximately more... | ||
| Medical Services | AmerisourceBergen Corporation (NYSE:ABC) | Health Advocates, Inc. |
| Adds functionality to AmerisourceBergen's workers' compensation services business. Deal value - $83m, on $20m of revenue (4.1x). Medicare more... | ||
| Medical Services | AmerisourceBergen Corporation (NYSE:ABC) | Access M.D., Inc. |
| Expands ABC's specialty pharmaceutical services in the Canadian market. Deal value -- more... | ||
| Medical Services | CareGuide, Inc (OTCBB:CGDE) | Haelan Corporation |
| Brings to CareGuide a predictive modeling capacity that identifies at-risk members for high near-term healthcare utilization. Deal terms -- $1.5m more... | ||
| Medical Services | CVS Corp. | Caremark Rx Inc. |
| Adds Caremark's growing mail order business to CVS' retail franchise, creating a $75b drug distribution powerhouse that could compete more more... | ||
| Medical Services | Fiserv Inc. (NASDAQ:FISV) | Innovative Cost Solutions |
| Furthers Fiserv Health's strategy of providing a full range of cost management solutions to medical payers. Terms not more... | ||
| Medical Services | Healthways, Inc. (NASDAQ: HWAY) | Axia Health Management, LLC |
| Adds to Healthways' spectrum of integrated, personalized, evidence-based health and wellness services. Axia’s national network enables more... | ||
| Medical Services | Meritain Health, Inc. | CBSA PERFORMAX |
| Doubles the size of Meritain Health, creating the nation's largest privately held manager of health benefits plans. The combined company will more... | ||
| Medical Services | On Assignment, Inc. (Nasdaq: ASGN) | VISTA Staffing Solutions |
| Expands On Assignment's healthcare staffing services to include physician staffing, and adds a third segment to the Company's growing more... | ||
| Medical Services | Platinum Equity | Healthcare Marketing Services unit of Cardinal Health (NYSE: CAH) |
| With more than $200m in revenue, HMS provides sales and marketing communications services and materials to the pharmaceutical and biotechnology more... | ||
| Medical Services | Psychiatric Solutions, Inc. (NASDAQ: PSYS) | Horizon Health Corporation (NASDAQ: HORC) |
| Enables PSI to expand its behavioral health business in growing markets. Identified opportunities to expand Horizon Health's EBITDA of $31m more... | ||
| Medical Services | Radiation Therapy Services, Inc. (Nasdaq: RTSX) | MIRO Cancer Centers and Michigan Comprehensive Cancer Institute |
| Adds a network of 7 radiation therapy treatment centers in Southeastern Michigan. The acquisition follows RTSX's entry into the Los Angeles local more... | ||
| Medical Services | TA Associates | American Access Care (AAC) |
| A $130m minority leveraged recap of a rapidly growing operator of vascular access facilities for dialysis patients. The services help reduce more... | ||
| OTC/Consumer | Chattem, Inc. (NASDAQ: CHTT) | The U.S. rights to certain brands from J&J and the consumer healthcare business of Pfizer Inc. |
| Expands Chattem's diverse portfolio of high quality brands into several new niche categories (including ACT mouthwash, Balmex diaper rash more... | ||
| OTC/Consumer | GlaxoSmithKline plc (NYSE: GSK) | CNS, Inc. (NASDAQ: CNXS) |
| Comports with GSK's growth strategy to add global consumer brand names with high growth. Deal value -- $566m on sales of $122.2 more... | ||
| OTC/Consumer | Johnson & Johnson | Pfizer Inc.'s consumer healthcare business. |
| Increases J&J's lead in the market for non-prescription health products. Adds Listerine mouthwash, Sudafed decongestant, Nicorette more... | ||
| OTC/Consumer | The Procter & Gamble Company (NYSE: PG) | Inverness Medical Innovations, Inc. (Amex: IMA) |
| 50/50 joint venture for the development and sale of existing and to-be-developed consumer diagnostic products outside of the fields of cardiology and more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||